Long-term low-dose sulforaphane treatment of fibroblasts enhanced the release of anti-remodeling cardiomyocyte-targeted fibroblast-derived exosomes, which effectively prevented the onset of heart failure.
[Journal Of Translational Medicine]
Home Newsletters Muscle Cell News Cardiomyocyte-Targeting Exosomes From Sulforaphane-Treated Fibroblasts Affords Cardioprotection in Infarcted Rats
